218 related articles for article (PubMed ID: 12031372)
21. Identification, pharmacologic considerations, and management of prostatitis.
Schiller DS; Parikh A
Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
[TBL] [Abstract][Full Text] [Related]
22. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Shoskes DA; Nickel JC; Kattan MW
Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
Wang J; Yan D; Liang K; Xu Z
Int Urol Nephrol; 2016 Jan; 48(1):13-8. PubMed ID: 26577998
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
[TBL] [Abstract][Full Text] [Related]
25. Men suffering from category III chronic prostatitis may benefit from N-acetylcysteine as an adjunct to alpha-blockers.
Yaryari AM; Mousavibahar SH; Amirhassani S; Bagheri M; Mohammadi Y; Mehrpooya M
Low Urin Tract Symptoms; 2022 May; 14(3):199-207. PubMed ID: 35068061
[TBL] [Abstract][Full Text] [Related]
26. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
Yang G; Wei Q; Li H; Yang Y; Zhang S; Dong Q
J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
28. Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: study protocol for a randomized controlled trial.
Qin Z; Liu Y; Zhou K; Wu J; Pang R; Li N; Xu C; Kwong JSW; Liu Z
Trials; 2017 Dec; 18(1):616. PubMed ID: 29273095
[TBL] [Abstract][Full Text] [Related]
29. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.
Anothaisintawee T; Attia J; Nickel JC; Thammakraisorn S; Numthavaj P; McEvoy M; Thakkinstian A
JAMA; 2011 Jan; 305(1):78-86. PubMed ID: 21205969
[TBL] [Abstract][Full Text] [Related]
30. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
[TBL] [Abstract][Full Text] [Related]
31. Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.
Nickel JC; O'Leary MP; Lepor H; Caramelli KE; Thomas H; Hill LA; Hoel GE
J Urol; 2011 Jul; 186(1):125-31. PubMed ID: 21571345
[TBL] [Abstract][Full Text] [Related]
32. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment.
Gao M; Ding H; Zhong G; Lu J; Wang H; Li Q; Wang Z
Urology; 2012 Feb; 79(2):391-6. PubMed ID: 22100490
[TBL] [Abstract][Full Text] [Related]
33. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
Kaplan SA; Volpe MA; Te AE
J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
[TBL] [Abstract][Full Text] [Related]
34. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Jeong CW; Lim DJ; Son H; Lee SE; Jeong H
Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
[TBL] [Abstract][Full Text] [Related]
35. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
36. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
[TBL] [Abstract][Full Text] [Related]
37. Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial.
De Rose AF; Gallo F; Giglio M; Carmignani G
Urology; 2004 Jan; 63(1):13-6. PubMed ID: 14751338
[TBL] [Abstract][Full Text] [Related]
38. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
[TBL] [Abstract][Full Text] [Related]
39. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
[TBL] [Abstract][Full Text] [Related]
40. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis.
Altintas R; Oguz F; Beytur A; Ediz C; Gunes A; Ozer A
Actas Urol Esp; 2013; 37(10):619-24. PubMed ID: 23768504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
